From Google Scholar & other sources: Selected Journal Articles, Dissertations, Theses 

The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan
K Yamabe, PK Singhal, M Abe, EJ Dasbach… – Value in Health Regional …, 2013
Objective We assessed the epidemiological and economic impact of a quadrivalent human
papillomavirus (HPV)(6/11/16/18) vaccine for females in preventing cervical cancer, cervical
intraepithelial neoplasia grades 2 and 3 (CIN 2/3), cervical intraepithelial neoplasia grade …

National Vaccine Prevention Plan (PNPV) 2012-2014 in the Italian Regions].
C Carlino, L Zaratti, G Lucciola, E Franco – Igiene e sanità pubblica, 2013
Seven years after the previous National Vaccines Plan (PNV) 2005-2007 the new PNPV
2012-2014 was ratified with the approval of both National and Regional Authorities in
February 22, 2012. The implementation state of the new Plan at 31/12/2012 was …

[HTML] Challenges in the research and development of new human vaccines
T Barbosa, M Barral-Netto – Brazilian Journal of Medical and Biological Research, 2013
… The literature tends to focus more often on vaccine research problems associated with specific
pathogens, but it is increasingly clear that there are common bottlenecks in vaccine research,
which need to be solved in order to advance the development of the field as a whole. …

Screening for Hepatitis B
D Tarrant, J Block, B McMahon – The Journal for Nurse Practitioners, 2013
… Keywords. chronic; disease management; hepatitis B; liver; liver cancer; screening. Chronic
infection with the hepatitis B virus (HBV) remains a serious public health problem in the United
States, despite the availability of an effective vaccine and universal infant vaccination. …

[PDF] Community knowledge, attitude and practice of childhood immunization in Southwest Nigeria: Data from a Paediatric Association of Nigeria town hall meeting.
CI Esezobor, N Lagos, MR Balogun, M Mukhtar-Yola… – Niger J Paed, 2013
… Esangbedo DO Paediatrics Unit, Providence Hospital, Lagos, Nigeria Abstract Background:
Vaccine preventable diseases account for 22% of under-five deaths in Nigeria and poor
knowledge and attitude have been responsible for non-vaccination of children. …

LIVE, ORAL VACCINE FOR PROTECTION AGAINST SHIGELLA DYSENTERIAE SEROTYPE 1
DJ Kopecko – US Patent 20,130,078,274, 2013
Abstract: The invention relates to Salmonella typhi Ty21a comprising core-linked Shigella
dysenteriae serotype 1 O-specific polysaccharide (O-Ps) and DNA encoding O antigen
biosynthesis, said DNA selected from the group consisting of: a) the DNA sequence set …